Metformin doses to ensure efficacy and safety in patients with reduced kidney function

The safety and pharmacokinetics of metformin in patients with chronic liver disease

(2020) Felicity C. Smith et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Association between Metformin Therapy and Lactic Acidosis

(2019) Isabelle H. S. Kuan et al.   DRUG SAFETY

Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or 4

(2018) Jean-Daniel Lalau et al.   DIABETES CARE

A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function

(2017) Janna K. Duong et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Lactic acidosis: relationship between metformin levels, lactate concentration and mortality

(2016) D. Boucaud-Maitre et al.   DIABETIC MEDICINE

Therapeutic Concentrations of Metformin: A Systematic Review

(2015) Farshad Kajbaf et al.   CLINICAL PHARMACOKINETICS

A New Equation to Estimate Glomerular Filtration Rate

(2013) Andrew S. Levey et al.   ANNALS OF INTERNAL MEDICINE

Population Pharmacokinetics of Metformin in Healthy Subjects and Patients with Type 2 Diabetes Mellitus: Simulation of Doses According to Renal Function

(2013) Janna K. Duong et al.   CLINICAL PHARMACOKINETICS

Establishment of a Database of Metformin Plasma Concentrations and Erythrocyte Levels in Normal and Emergency Situations

(2011) Jean-Daniel Lalau et al.   CLINICAL DRUG INVESTIGATION

Clinical Pharmacokinetics of Metformin

(2011) Garry G. Graham et al.   CLINICAL PHARMACOKINETICS